PharmaShots | Incisive News in 3 Shots

Subscribe Now

Free

AbbVie's Imbruvica (ibrutinib) + Gazyva (obinutuzumab) Receives FDA's Approval- First CT Free Treatment for 1L+ CLL/SLL

AbbVie's Imbruvica (ibrutinib) + Gazyva (obinutuzumab) Receives FDA's Approval- First CT Free Treatment for 1L+ CLL/SLL

January 28, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us